Pharvaris Bv Stock Price Prediction

PHVS Stock  USD 21.04  0.54  2.63%   
At this time, The RSI of Pharvaris' share price is at 53 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Pharvaris, making its price go up or down.

Oversold Vs Overbought

53

 
Oversold
 
Overbought
The successful prediction of Pharvaris' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Pharvaris and does not consider all of the tangible or intangible factors available from Pharvaris' fundamental data. We analyze noise-free headlines and recent hype associated with Pharvaris BV, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Pharvaris' stock price prediction:
EPS Estimate Next Quarter
(0.73)
EPS Estimate Current Year
(2.65)
EPS Estimate Next Year
(2.98)
Wall Street Target Price
33.1026
EPS Estimate Current Quarter
(0.65)
Using Pharvaris hype-based prediction, you can estimate the value of Pharvaris BV from the perspective of Pharvaris response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pharvaris to buy its stock at a price that has no basis in reality. In that case, they are not buying Pharvaris because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Pharvaris after-hype prediction price

    
  USD 21.04  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Pharvaris Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharvaris' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
13.8517.7221.59
Details
Naive
Forecast
LowNextHigh
17.0420.9124.77
Details
7 Analysts
Consensus
LowTargetHigh
21.9824.1526.81
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.77-0.66-0.62
Details

Pharvaris After-Hype Price Prediction Density Analysis

As far as predicting the price of Pharvaris at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharvaris or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pharvaris, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Pharvaris Estimiated After-Hype Price Volatility

In the context of predicting Pharvaris' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharvaris' historical news coverage. Pharvaris' after-hype downside and upside margins for the prediction period are 17.17 and 24.91, respectively. We have considered Pharvaris' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
21.04
21.04
After-hype Price
24.91
Upside
Pharvaris is not too volatile at this time. Analysis and calculation of next after-hype price of Pharvaris BV is based on 3 months time horizon.

Pharvaris Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Pharvaris is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharvaris backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharvaris, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.23 
3.87
  0.05 
  0.02 
5 Events / Month
11 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
21.04
21.04
0.00 
1,683  
Notes

Pharvaris Hype Timeline

Pharvaris BV is at this time traded for 21.04. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of 0.02. Pharvaris is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.23%. %. The volatility of related hype on Pharvaris is about 4993.55%, with the expected price after the next announcement by competition of 21.06. About 88.0% of the company shares are owned by institutional investors. The book value of Pharvaris was at this time reported as 7.35. The company recorded a loss per share of 2.74. Pharvaris BV had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days.
Check out Pharvaris Basic Forecasting Models to cross-verify your projections.

Pharvaris Related Hype Analysis

Having access to credible news sources related to Pharvaris' direct competition is more important than ever and may enhance your ability to predict Pharvaris' future price movements. Getting to know how Pharvaris' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharvaris may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PMVPPmv Pharmaceuticals(0.1)3 per month 2.12 (0.02) 3.75 (3.77) 13.98 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.18) 6.21 (9.35) 34.87 
MNOVMediciNova 0.16 9 per month 4.13  0.11  14.50 (8.50) 61.30 
PEPGPepGen 0.39 9 per month 0.00 (0.28) 4.75 (9.02) 26.81 
MOLNMolecular Partners AG(0.10)5 per month 5.15 (0.01) 9.61 (8.53) 52.92 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.43  0.01  6.27 (5.79) 20.98 
ANTXAN2 Therapeutics 0.00 11 per month 1.89  0.03  2.88 (3.42) 10.00 
GLUEMonte Rosa Therapeutics(0.25)7 per month 4.44  0.06  10.11 (8.29) 102.66 
DSGNDesign Therapeutics 0.06 4 per month 5.44  0.03  9.61 (8.21) 35.31 
HOWLWerewolf Therapeutics(0.02)6 per month 0.00 (0.02) 9.21 (8.75) 49.02 
IKNAIkena Oncology(0.05)3 per month 1.38 (0.06) 1.81 (1.74) 13.50 
STOKStoke Therapeutics(0.04)7 per month 0.00 (0.12) 4.68 (7.09) 21.35 
TYRATyra Biosciences 0.87 9 per month 0.00 (0.11) 5.20 (6.06) 34.43 
ANEBAnebulo Pharmaceuticals(0.07)6 per month 0.00 (0.02) 8.85 (11.48) 76.00 
JANXJanux Therapeutics(0.18)9 per month 2.58 (0) 6.45 (4.58) 15.08 
RZLTRezolute 0.18 8 per month 3.10  0.03  6.81 (5.54) 30.01 

Pharvaris Additional Predictive Modules

Most predictive techniques to examine Pharvaris price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharvaris using various technical indicators. When you analyze Pharvaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Pharvaris Predictive Indicators

The successful prediction of Pharvaris stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharvaris BV, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharvaris based on analysis of Pharvaris hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharvaris's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharvaris's related companies.
 2021 2022 2023 2024 (projected)
PB Ratio1.882.362.542.41
Capex To Depreciation1.680.810.350.33

Story Coverage note for Pharvaris

The number of cover stories for Pharvaris depends on current market conditions and Pharvaris' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharvaris is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharvaris' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Pharvaris Short Properties

Pharvaris' future price predictability will typically decrease when Pharvaris' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharvaris BV often depends not only on the future outlook of the potential Pharvaris' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharvaris' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding38.4 M
Cash And Short Term Investments391.6 M

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.